Celldex Therapeutics shares owned by Kynam Capital Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Kynam Capital Management
from 13F filings
Historical chart of Kynam Capital Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Kynam Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $125M | 3.4M | 37.01 |
| 2024-03-31 | $122M | 2.9M | 41.97 |
| 2023-12-31 | $119M | 3.0M | 39.66 |
| 2023-09-30 | $88M | 3.2M | 27.52 |
| 2023-06-30 | $88M | 2.6M | 33.93 |
| 2023-03-31 | $51M | 1.4M | 35.98 |
| 2022-12-31 | $72M | 1.6M | 44.57 |
| 2022-09-30 | $45M | 1.6M | 28.11 |
| 2022-06-30 | $37M | 1.4M | 26.96 |
| 2022-03-31 | $26M | 753k | 34.06 |
| 2021-12-31 | $8.8M | 227k | 38.64 |